Kirke Hyllinge, Denmark

Peder Mohr Olsen



 

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 61(Granted Patents)


Location History:

  • Kr. Hyllinge, DK (2008)
  • Kirke Hyllinge, DK (2014 - 2019)

Company Filing History:


Years Active: 2008-2019

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Peder Mohr Olsen: Innovator in Pharmaceutical Materials

Introduction

Peder Mohr Olsen is a notable inventor based in Kirke Hyllinge, Denmark. He has made significant contributions to the field of pharmaceutical materials, holding a total of 9 patents. His work primarily focuses on the development of particulate materials that enhance the efficacy of solid dosage forms.

Latest Patents

One of Olsen's latest patents involves a particulate comprising a calcium-containing compound and a sugar alcohol. This invention relates to a particulate material and a solid dosage form, notably tablets, that include a regularly shaped calcium-containing compound, such as a calcium salt, as a therapeutically and/or prophylactically active substance. The formulation also incorporates a pharmaceutically acceptable sugar alcohol, such as sorbitol and/or isomalt, which exhibits a microstructure as evidenced by scanning electron microscopy (SEM). The process for preparing this particulate material involves agglomeration through roller compaction, making it suitable for further processing into tablets, including chewing tablets.

Career Highlights

Throughout his career, Peder Mohr Olsen has worked with prominent companies in the pharmaceutical industry, including Takeda Nycomed and Takeda. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Olsen has collaborated with several professionals in his field, including Poul Bertelsen and Carsten Martini Nielsen. These collaborations have likely enriched his research and development efforts.

Conclusion

Peder Mohr Olsen's contributions to the field of pharmaceutical materials are noteworthy, particularly his innovative approaches to particulate formulations. His patents reflect a commitment to advancing therapeutic options in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…